Terns Pharmaceuticals Inc (TERN)
5.905
-0.24
(-3.83%)
USD |
NASDAQ |
May 17, 16:00
5.905
0.00 (0.00%)
After-Hours: 18:26
Terns Pharmaceuticals Accounts Payable (Quarterly): 1.701M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.701M |
December 31, 2023 | 2.515M |
September 30, 2023 | 3.325M |
June 30, 2023 | 5.537M |
March 31, 2023 | 2.69M |
December 31, 2022 | 1.645M |
September 30, 2022 | 2.094M |
June 30, 2022 | 0.973M |
Date | Value |
---|---|
March 31, 2022 | 1.678M |
December 31, 2021 | 2.126M |
September 30, 2021 | 1.582M |
June 30, 2021 | 1.688M |
March 31, 2021 | 4.25M |
December 31, 2020 | 0.935M |
September 30, 2020 | 0.461M |
December 31, 2019 | 1.636M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.461M
Minimum
Sep 2020
5.537M
Maximum
Jun 2023
2.177M
Average
1.694M
Median
Accounts Payable (Quarterly) Benchmarks
Viking Therapeutics Inc | 5.225M |
Eli Lilly and Co | 2.474B |
Pfizer Inc | 5.591B |
Amgen Inc | 1.628B |
Madrigal Pharmaceuticals Inc | 21.53M |